AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer

10.1158/1078-0432.CCR-13-1354

Saved in:

Bibliographic Details
Main Authors:	Dunne, P.D., McArt, D.G., Blayney, J.K., Kalimutho, M., Greer, S., Wang, T., Srivastava, S., Ong, C.W., Arthur, K., Loughrey, M., Redmond, K., Longley, D.B., Salto-Tellez, M., Johnston, P.G., Van Schaeybroeck, S.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/116236
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-116236
record_format	dspace
spelling	sg-nus-scholar.10635-1162362023-10-29T21:55:13Z AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer Dunne, P.D. McArt, D.G. Blayney, J.K. Kalimutho, M. Greer, S. Wang, T. Srivastava, S. Ong, C.W. Arthur, K. Loughrey, M. Redmond, K. Longley, D.B. Salto-Tellez, M. Johnston, P.G. Van Schaeybroeck, S. CANCER SCIENCE INSTITUTE OF SINGAPORE 10.1158/1078-0432.CCR-13-1354 Clinical Cancer Research 20 1 164-175 CCREF 2014-12-12T07:47:23Z 2014-12-12T07:47:23Z 2014-01-01 Article Dunne, P.D., McArt, D.G., Blayney, J.K., Kalimutho, M., Greer, S., Wang, T., Srivastava, S., Ong, C.W., Arthur, K., Loughrey, M., Redmond, K., Longley, D.B., Salto-Tellez, M., Johnston, P.G., Van Schaeybroeck, S. (2014-01-01). AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer. Clinical Cancer Research 20 (1) : 164-175. ScholarBank@NUS Repository. https://doi.org/10.1158/1078-0432.CCR-13-1354 10780432 http://scholarbank.nus.edu.sg/handle/10635/116236 000329303100019 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1158/1078-0432.CCR-13-1354
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Dunne, P.D. McArt, D.G. Blayney, J.K. Kalimutho, M. Greer, S. Wang, T. Srivastava, S. Ong, C.W. Arthur, K. Loughrey, M. Redmond, K. Longley, D.B. Salto-Tellez, M. Johnston, P.G. Van Schaeybroeck, S.
format	Article
author	Dunne, P.D. McArt, D.G. Blayney, J.K. Kalimutho, M. Greer, S. Wang, T. Srivastava, S. Ong, C.W. Arthur, K. Loughrey, M. Redmond, K. Longley, D.B. Salto-Tellez, M. Johnston, P.G. Van Schaeybroeck, S.
spellingShingle	Dunne, P.D. McArt, D.G. Blayney, J.K. Kalimutho, M. Greer, S. Wang, T. Srivastava, S. Ong, C.W. Arthur, K. Loughrey, M. Redmond, K. Longley, D.B. Salto-Tellez, M. Johnston, P.G. Van Schaeybroeck, S. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
author_sort	Dunne, P.D.
title	AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
title_short	AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
title_full	AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
title_fullStr	AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
title_full_unstemmed	AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
title_sort	axl is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/116236
_version_	1781789487596044288

AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer

Similar Items